OKYO Pharma (OKYO) Earnings Date & Reports

OKYO Pharma Ltd is a clinical-stage ophthalmology company focused on developing differentiated therapies for corneal and anterior segment diseases... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

OKYO is expected to report earnings to rise 33.33% to -3 cents per share on December 02

Q3'26

Est.

$-0.04

Q2'26

Missed

by $0.01

Q1'26

Beat

by $0.05

Q4'25

Est.

$-0.05

Q3'25

Beat

by $0.02

The last earnings report on September 02 showed earnings per share of -2 cents, missing the estimate of -1 cents. With 33.82K shares outstanding, the current market capitalization sits at 72.95M.

View a ticker or compare two or three

OKYO

Daily Signal:

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

View AI-Driven Trading for OKYO